The Flect Ct Imaging Market report tabled by Persistence Market Research focuses on the parameters of the 4th industrial revolution, which includes technology-driven healthcare solutions, with several breakthroughs in this regard. The entire supply chain – right from diagnostics to the delivery of medicines, is being driven by the technological advancements in healthcare.

The Flect Ct Imaging Market report by Persistence Market Research goes by the changing trend of consumerism all across the healthcare vertical. “Going cashless” is amongst the “new” normals. Inorganic growth has also picked up. Key participants of the healthcare value chain – both – private and public – have joined hands for competing in the ever-demanding landscape.

The three-dimensional fluorescence bio imager called Fluorescence Emission Computed Tomography (FLECT) is used for the detection of a novel recombinant fluoroprobe that is safe, easily prepared on a large scale and stably stored prior to scan. It is a small animal imaging platform that combines fluorescence emission computed tomography (FLECT) and an inline X-ray CT into a single instrument that gives molecular imaging capability with anatomical reference.

The FLECT/CT offers industry-first, complete angle tomography data acquisition, which is superior in accuracy and sensitivity compared to the raster scanning approaches used by other optical imaging instruments claiming fluorescence tomography capabilities.

Get Sample Copy of this Report@

The FLECT/CT has been used in a wide variety of preclinical research applications, including cancer, theranostics, probe development, drug delivery, cardiovascular research, and neuroscience. With an industry-first, rotating gantry design for complete angle fluorescence tomography data acquisition, FLECT/CT enables radioisotope-free, molecular imaging in deep tissue. In the past few decades, we have witnessed significant improvements in imaging technology in preclinical and clinical translational research and its applications. Optical imaging, particular fluorescence imaging, is widely used in histologic examination of cells, and has gained clinical interest.

Essential in the management of medical conditions and diseases virtually, there is growing interest in R&D of newer and more powerful imaging technologies. Surge in adoption of sophisticated diagnostic technologies coupled with increased early diagnosis have expected to accelerate preclinical imaging market. In addition, Companies adopting product innovations to increase their market share. Also rapidly growing geriatric population and the rise in associated diseases, rising healthcare, expenditure technological innovations drive the global FLECT/CT Imaging Market.

Request for Table of Content@

In 2021, 1,898,160 new cancer cases and 608,570 cancer deaths are estimated to occur in the United States. It is further projected that the total incidence rate of worldwide cancer will increase by 62% from 2018-2040. This leads to increase in demand of preclinical animal studies to effectively monitor and quantitate the therapeutic responses and use this in the drug development program. Small animal optical imaging provides oncology researchers with the ability to perform non-invasive longitudinal monitoring of disease progression, detection of metastasis and micro metastasis, and to accurately quantify tumour burden in a wide variety of animal models.

Stringent regulatory restrictions on the animals used in preclinical studies is expected to restrain growth of FLECT/CT Imaging market. The ultimate goals of preclinical studies are to accurately model, in animals, the desired biological effect of a drug in order to predict treatment outcome in patients (efficacy), and to identify and characterize all toxicities associated with a drug in order to predict adverse events in people (safety) for informed risk assessment. But these regulations leads to limitations to opportunities for drug preclinical studies leading to less chances of drug development. Also the high cost can especially be a cause for concern in emerging markets.

Access Full Report@

Market Segmentation:

Based on the dimensional shape:

  • 2D- Fluorescence reflectance
  • 3D- Complete angle fluorescence tomography

Based on imaging modality:

  • Optical Imaging (complete angle tomography, 2D reflectance)
  • MicroCT Imaging (complete angle tomography, 2D radiograph)

Based on the distribution channel, the FLECT/CT Imaging Market has been segmented as:

  • Hospitals
  • Research institutes
  • Research laboratories
  • Pharmaceutical companies

Based on the region, the FLECT/CT Imaging Market has been segmented as:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East & Africa

Key players are Trifoil imaging, Bioscan Inc. actively involved in providing this technology for various purposes. As this is a newly developed imaging device, there are not much manufacturers of the device.

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers’ experience by acting as the “missing” link between “customer relationships” and “business outcomes’. The best possible returns are assured therein.

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales –
Website –